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Aim To evaluate competitive enzyme-linked immunosor-
bent assay (cELISA) for its suitability as an additional sero-
logical test for the diagnosis of animal brucellosis.
Methods cELISA, which was developed at the Veterinary 
Laboratories Agency, has been evaluated for its accuracy 
and suitability as an additional serological test for the diag-
nosis of animal brucellosis. Samples from naturally and ex-
perimentally infected animals and those from Brucella-free 
flocks and herds were tested.
Results Data obtained since 1991 were analyzed from rou-
tine surveillance, animals experimentally infected with Bru-
cella, and stored sera to validate cELISA for the detection of 
antibodies to Brucella in cows, small ruminants, and pigs. 
The sensitivity of the test ranged from 92.31% to 100%, in 
comparison with 77.14% to 100% for the complement fix-
ation test (CFT). Specificities for cELISA, indirect enzyme-
linked immunosorbent assay, and CFT were greater than 
90%.
Conclusion cELISA can be used on a variety of animal spe-
cies, and an added advantage is its suitability for use on 
poor-quality samples such as those affected by hemolysis.
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In accordance with EC Directive 91/68/EEC, flocks of sheep 
and herds of goats in the United Kingdom (UK)are moni-
tored serologically to prove that they are free from Brucel-
la melitensis. In 2006, competitive enzyme-linked immu-
nosorbent assay (cELISA) was introduced to screen these 
animals as part of a surveillance program in Great Britain 
(GB), the territory including all of the UK except for North-
ern Ireland. It replaced the complement fixation test (CFT) 
because of its much higher specificity and ease of automa-
tion. Currently, in excess of 35 000 animals are tested an-
nually.
In 2001, a revision to the pig semen directive was intro-
duced by EC Directive 99/608 so that CFT was replaced 
with the Rose Bengal test (RBT) as the test used for brucel-
losis on all pigs whose semen is used for artificial insemina-
tion. RBT and CFT were run in parallel in addition to cELISA 
prior to this date in order to assess the effects of changing 
the testing regime and, at the same time, to validate the 
use of cELISA for pigs. During 2001, all routine samples that 
were tested for artificial insemination purposes and were 
positive by RBT were also tested by cELISA and the results 
analyzed using different diagnostic thresholds. The aim 
was to set an appropriate threshold that would provide 
optimal specificity and sensitivity for cELISA.
CFT, RBT, and indirect enzyme linked immunosorbent as-
say (iELISA) are the conventionally used tests for diagno-
sis of bovine brucellosis. These tests are described in the 
Manual for Diagnostic Tests and Vaccines for Terrestrial 
Animals produced by the World Organisation for Animal 
Health, previously the Office International des Epizooties 
(OIE) (1), and this manual gives details of all the diagnostic 
methods. It also describes the strain of Brucella required for 
antigen preparation and the procedure for standardization 
for each test.
The cELISA for the detection of antibodies against Brucel-
la spp. was adapted at the Veterinary Laboratories Agen-
cy (VLA) from the method described by MacMillan et al 
in 1990 (2). It was initially developed for the diagnosis of 
brucellosis in small ruminants and was tested extensively 
on British sheep and on sheep and goats from France. It 
has also since been tested on large numbers of cattle and 
pigs.
The aim of this study was to bring together and compare 
all brucellosis testing results carried out using cELISA, RBT, 
and iELISA at the VLA since 1991. The samples had been 
collected and analyzed within the framework of various 
surveillance screening programs and experimental stud-
ies. The present study demonstrates the effectiveness of 
cELISA compared with other assays currently used as diag-
nostic tests of brucellosis in domestic animals.
MethoDS
Study design
This study performed retrospective comparisons of diag-
nostic testing of samples that had been collected at differ-
ent periods from various regions of France and GB. For ex-
ample, approximately 1 million bovine blood samples were 
routinely tested annually for evidence of Brucella infection 
up until 2007. Samples had been collected and analyzed in 
previous years as described below. In some cases, samples 
previously collected and stored frozen were thawed and 
tested for the purposes of this study. A proportion of sam-
ples were from animals that were found to be unsuitable 
for testing by confirmatory tests, most often CFT. cELISA 
was used on all samples unsuitable for CFT as it is techni-
cally straightforward to perform and is unaffected by the 
age and condition of the sample (3).
All animal work was approved by the VLA ethics commit-
tee and is in line with the Animal (Scientific Procedures) 
Act.
optimization of antigen and monoclonal antibody for 
ceLISA
An M dominant epitope lipopolysaccharide was extracted 
from Brucella melitensis strain 16M by the hot phenol meth-
od (4) as the antigen for coating the plates. An anti-M epit-
ope monoclonal antibody (mAb) BM40 (5) was conjugated 
with horseradish peroxidase (HRP) by the method adapted 
from Nakane and Kawaoi (6). HRP (20 mg) was dissolved 
in 5 mL of distilled water, and 1 mL of freshly prepared 0.1 
M sodium periodate was added. After stirring for 20 min-
utes at room temperature, the activated HRP was dialyzed 
against 1 mM sodium acetate (pH 4.0) for 15 to 20 hours. 
The dialyzed HRP and 20 mg of mAb were separately ad-
justed to pH 9 with 10 mM sodium carbonate buffer (pH 
9.5) before being combined and then stirred at room tem-
perature for 2 hours. Ascorbic acid (4 mg/mL, 0.5 mL) was 
added and after 4 hours of incubation at 4°C with continu-
ous stirring, the mixture was dialyzed between 15 and 20 
hours against several changes of 0.1 M phosphate-buff-
ered saline. The conjugate was filtered through a 100-
kDa microcentrifuge filter (Sigma M-2286), added to 
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an equal volume of glycerol and stored at -20°C until re-
quired.
The optimal concentration of antigen and conjugate for 
use in cELISA was determined by titration against stan-
dard sera from a known brucellosis-free sheep and se-
rum from a goat experimentally infected with B. meli-
tensis strain H38. The M dominant B. melitensis antigen 
and anti-M mAb were selected because the M epitope 
is considered to be specific to brucellosis, which may 
help to reduce the incidence of false positive reactions 
caused by antibodies produced in response to infection 
by other bacteria. Antibodies produced as a result of in-
fection with all Brucella smooth strains may compete 
with BM40 (7) for epitopes on the lipopolysaccharide 
O-chain (8).
Conventional and ceLISA diagnostic testing
Subjective tests (CFT, RBT) were carried out by trained 
technicians using standard techniques (1). The cELISA as 
adapted by MacMillan (2) was carried out according to 
Stack et al (3). Two thresholds have been used during the 
course of this work. From 1991-1994, it was initially set 
so that samples whose optical densities at 450 nm were 
equal to or less than 75% of the negative control serum 
were considered positive. In 1994, the threshold for posi-
tivity was changed to be optical densities equal to or less 
than 60% of the conjugate control. This change was made 
to more accurately measure the inhibition of conjugated 
mAb binding.
Cattle
Non-infected animals. Samples from the 1994 domestic 
surveillance program were tested by cELISA. The samples 
comprised 640 animals that were negative by CFT, defined 
as less than 20 CFT International Units per mL, and 160 
negative by iELISA. In 2004, from a total 835278 animals 
in the domestic survey program in GB, 5608 animals that 
were classified as false positives by iELISA were tested by 
cELISA. In 2006, a further 2000 animals from GB were ran-
domly selected from the surveillance program and tested 
by cELISA and iELISA.
Infected animals. A total of 147 serum samples from in-
dividual cattle confirmed by culture as infected by B. 
abortus biovar 1 had been collected in GB during the 
1970s and early 1980s when brucellosis was still en-
demic. The sera had been kept at less than -20°C 
until their use in the present study. They were then test-
ed by cELISA and CFT.
Sheep and goats
Non-infected animals. Samples from 462 sheep and 2000 
goat samples from a previous research project carried out 
in 1991 were used. They had been collected from brucello-
sis-free flocks and herds in GB that were found to be nega-
tive during RBT screening. In 1992, iELISA and cELISA were 
used to test a further 6260 samples from sheep and goats 
from GB and 433 goats and 309 sheep from France. From 
the annual surveillance program for diagnosis of B. meliten-
sis in sheep and goats in 2006, another 36785 brucellosis-
free animals were tested using cELISA alone.
Infected animals. CFT and cELISA results were used from 
30 goats and 35 sheep from France that had been natu-
rally infected with Brucella melitensis. Both tests were also 
used to analyze additional 23 goats from France and 22 
sheep from GB that had been experimentally infected 
with B. melitensis strain H38 and bled at regular times post 
infection.
Pigs
Non-infected animals. From the routine samples collected 
during 2001 from pigs in GB, 2031 samples were tested us-
ing RBT and cELISA. In 2002, a further 1488 animals from 
herds in GB were tested by cELISA, RBT, and CFT.
Infected animals. Samples were obtained from 13 ani-
mals that tested culture-positive for B. suis: 10 came from 
the US National Veterinary Services Laboratories and 3 
from the State Veterinary Service in Denmark. These 
samples were tested by CFT and cELISA. In addition, 588 
samples obtained from herds from France where at least 
1 animal was culture-positive were tested by RBT, CFT, 
and cELISA.
Positive controls for all species. For cELISA and iELISA the 
positive control was from a goat artificially infected with B. 
melitensis H38. The positive controls used for RBT, CFT, and 
iELISA were bovine and of known titer, based on the OIE B. 
abortus International Reference Standard Serum.
Negative controls for all species. A pool of species-specific 
sera from Brucella-free animals in GB was used for all assays; 
these sera had originally been screened by RBT, iELISA, or 
cELISA.
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No vaccinated animals were included in this study due to the 
insufficient number of samples with reliable provenance.
ReSuLtS
The data obtained from the non-infected animals is shown 
in Table 1 and from infected animals in Table 2.
Sheep and goats
The specificity for sheep and goats, as seen in Table 1, 
is comparable for both cELISA and iELISA, with greater 
than 99% specificity for both tests. In 2006, the first full 
year when surveillance was carried out using cELISA in-
stead of CFT, 36 785 animals were tested with only one 
false positive, giving greater than 99.99% specificity (Ta-
ble 1).
The data from the naturally infected flocks and herds (Ta-
ble 2) shows that the sensitivity of cELISA (94.29%) is bet-
ter than that of CFT (77.14%) for sheep but is the same for 
goats (96.67%).
From the experimentally infected sheep in which samples 
were taken at regular time points post-infection, all sam-
ples (Table 2) were positive by cELISA and CFT, but cELISA 
detected infection in 12 of the 22 (55%) sheep 2-23 days 
earlier than CFT. For 6 (27%) of these animals the difference 
















Sheep United Kingdom    462  460  99.57    461  99.78
Sheep France    309  307  99.35    308  99.68
Goats United Kingdom   2000 1991  99.55   1999  99.95
Goats France    433  433 100    432  99.77
Sheep and goats Great Britain   6260 6250  99.84   6258  99.97
Sheep and goats Great Britain 36 785 ND NA 36 784  99.99
Cattle Great Britain    160  160 NA    159  99.38
Cattle Great Britain   5608    0 NA   5605  99.95
Cattle Great Britain   2000 2000 100   1999  99.95
RBT-negative samples RBT specificity
Pig Great Britain   2031 1777  87.49   2004  98.67
Pig Great Britain   1488 1269  85.28   1464  98.38
CFT-negative samples CFT specificity
Cattle Great Britain    640  640 NA    640 100
Pig Great Britain   1488 1389  93.34   1464  98.38
*ND – not done; NA – not applicable; ieLISA – indirect enzyme-linked immunosorbent assay; ceLISA – competitive eLISA; RBt – Rose Bengal test; CFt 
– complement fixation test.















Sheep* United Kingdom  22  22 100  22 100
Sheep† France  35  27  77.14  33  94.29
Goats* United Kingdom  23  23 100  23 100
Goats† France  30  29  96.67  29  96.67
Cattle† United Kingdom 147 137  93.2 144  97.96
Pig*† United States  10   8  80   9  90
Pig† Denmark   3   3 100   3 100
Pig‡ France 588 260  44.22 312  53.06
*experimentally infected.
†Naturally infected.
‡herd where at least one culture-positive animal was known.
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was greater than 6 days. Among the 23 goats that were 
bled at regular time points post-infection, 15 animals (65%) 
were detected positive 14-18 days earlier by cELISA than 
by CFT. No animals were detected earlier by CFT.
Cattle
The specificity of cELISA was comparable to that of CFT 
and iELISA for those samples that were originally negative 
by either iELISA or CFT. Of the 5608 false iELISA positives 
from the surveillance program, only 3 (0.05%) were posi-
tive by cELISA (Table 1).
Table 2 shows that the sensitivity of cELISA is better than 
that of CFT. Samples from culture-positive animals totaled 
147, 144 were cELISA-positive (97.96% sensitivity), and 139 
were CFT-positive (94.56% sensitivity).
Pigs
From the routine samples collected from pigs in GB and 
screened by RBT in 2001, 254 of the 2031 were RBT false 
positives, giving 87.49% specificity. With the threshold set at 
60% of the mean optical density of the conjugate control (as 
for cattle, sheep, and goats at this time), only 27 were false 
positives by cELISA, corresponding to 98.67% specificity. The 
number of false positives rose to 37 if the threshold was set 
at 75%, corresponding to 98.17% specificity. Of the addi-
tional 1488 animals tested, the number of false positives and 
specificity for each method were as follows: RBT, 219 false 
positives and 85.28% specificity; cELISA, 24 and 98.38%; CFT, 
99 and 93.34%. Additional 56 animals were anticomplemen-
tary and therefore required re-sampling (Table 1).
Twelve of the 13 culture-positive animals were positive by 
both cELISA and CFT. From the 588 animals for which the 
herd contained at least one culture-positive animal, 312 
(53%) were positive by cELISA, 260 (44%) by CFT, and 434 
(74%) by RBT (Table 2).
DISCuSSIoN
cELISA showed a higher specificity than either RBT or CFT 
for pig samples, but for other domestic animals it was only 
marginally more specific than iELISA. Generally more ani-
mals from the infected herds were positive by cELISA than 
by CFT. The exception to this is in pigs, in which there 
were fewer positives by cELISA than RBT. Some of the “ad-
ditional” positive pigs detected by RBT may be attrib-
uted to false positive reactions, which are notorious 
in pigs (9). Alternatively, the data from the French pigs may 
be inaccurate, since the samples were obtained from herds 
with only one known culture-positive animal; thus, the sta-
tus of the remaining animals was unknown. The high cost 
of being able to infect enough animals for experimen-
tal infection and the difficulty of obtaining material from 
known infected animals make conclusive determination of 
sensitivity difficult. More studies need to be done on in-
fected pigs to elucidate sensitivity and determine a suit-
able threshold for positivity.
The use of cELISA in addition to, or as a replacement for, 
conventional tests for brucellosis offers many benefits. 
Samples that are received in the laboratory that have de-
teriorated are often un-testable. These samples delay re-
sults and can incur additional costs to the farmer if animals 
have to be re-bled. An additional validated test is a neces-
sity in these situations if not to entirely replace assays cur-
rently used, then to provide extra information. This applies 
to most domestic species but from our experience at VLA, 
porcine samples are the ones that most frequently suffer 
hemolysis or anticomplementary reactions.
The cELISA procedures for detection of porcine antibody 
to Brucella spp. are identical to those used for bovine an-
tibody to B. abortus and B. melitensis, making the test valid 
for multiple animal species. This assay is capable of elimi-
nating some reactions due possibly to Y. enterocolitica se-
rotype 0.9 or other cross-reacting antibodies, such as IgM, 
which have lower affinity for Brucella epitopes than does 
the mAb used in the assay (10). cELISA is a prescribed test 
for international trade but none of the conventional sero-
logical tests has been shown to be entirely reliable for rou-
tine diagnosis in individual pigs (1).
There is continuing validation from the annual surveillance 
program for B. melitensis carried out in GB, providing re-
sults for more than 35 000 sheep and goats a year. Since 
it replaced CFT, cELISA has reduced the number of false 
positives and the number of un-testable samples. cELISA 
is also being used to test serum and body fluids from ma-
rine mammals (unpublished data), since it is not animal 
species-specific and can be used on poor-quality samples 
where some conventional tests are unsuitable. Often ma-
terial from marine mammals is of poor quality because it 
has been obtained from carcasses that may have been 
dead for some time.
cELISA is a rapid assay, it is faster than CFT, and it can be au-
tomated and therefore the results can be measured objec-
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tively. This assay incorporates an mAb similar to that used 
by Stack et al (3), McGiven et al (11), and Jungersen et al (9) 
but different from that used in other reports (12-14), so it 
adds to the information we already have from the battery 
of tests currently used for brucellosis diagnosis. Continuing 
validation is ongoing as samples with reliable provenance 
become available.
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